Your browser doesn't support javascript.
loading
Potential negative pharmacodynamic interaction of spironolactone and abiraterone in two prostate cancer patients.
Vicente-Valor, Juan; Escudero-Vilaplana, Vicente; Collado-Borrell, Roberto; López-López, Cristina; Villanueva-Bueno, Cristina; Revuelta-Herrero, José Luis; Ruiz-Briones, Paula; Somoza-Fernández, Beatriz; Herranz, Ana; Sanjurjo, María.
Affiliation
  • Vicente-Valor J; Pharmacy Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Doctor Esquerdo, Madrid, Spain.
  • Escudero-Vilaplana V; Pharmacy Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Doctor Esquerdo, Madrid, Spain.
  • Collado-Borrell R; Pharmacy Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Doctor Esquerdo, Madrid, Spain.
  • López-López C; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Doctor Esquerdo, Madrid, Spain.
  • Villanueva-Bueno C; Pharmacy Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Doctor Esquerdo, Madrid, Spain.
  • Revuelta-Herrero JL; Pharmacy Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Doctor Esquerdo, Madrid, Spain.
  • Ruiz-Briones P; Pharmacy Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Doctor Esquerdo, Madrid, Spain.
  • Somoza-Fernández B; Pharmacy Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Doctor Esquerdo, Madrid, Spain.
  • Herranz A; Pharmacy Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Doctor Esquerdo, Madrid, Spain.
  • Sanjurjo M; Pharmacy Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Doctor Esquerdo, Madrid, Spain.
J Oncol Pharm Pract ; 28(5): 1259-1263, 2022 Jul.
Article in En | MEDLINE | ID: mdl-35037798
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Spironolactone / Prostatic Neoplasms, Castration-Resistant Type of study: Prognostic_studies Limits: Humans / Male Language: En Journal: J Oncol Pharm Pract Journal subject: FARMACIA Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Spironolactone / Prostatic Neoplasms, Castration-Resistant Type of study: Prognostic_studies Limits: Humans / Male Language: En Journal: J Oncol Pharm Pract Journal subject: FARMACIA Year: 2022 Document type: Article Affiliation country: Country of publication: